{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T23:46:30Z","timestamp":1769211990428,"version":"3.49.0"},"reference-count":6,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-023-02623-4","type":"journal-article","created":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T09:02:54Z","timestamp":1681290174000},"page":"2347-2350","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Dermatologic toxicities of anti-neoplastic immunotherapy in United States hospitalizations"],"prefix":"10.1007","volume":"315","author":[{"given":"Shrey","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiv","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William C.","family":"Lau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinod E.","family":"Nambudiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,12]]},"reference":[{"key":"2623_CR1","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41568-019-0116-x","volume":"19","author":"JJ Havel","year":"2019","unstructured":"Havel JJ, Chowell D, Chan TA (2019) The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy. Nat Rev Cancer 19:133\u2013150","journal-title":"Nat Rev Cancer"},{"key":"2623_CR2","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.abd.2020.01.001","volume":"95","author":"J Cury-Martins","year":"2020","unstructured":"Cury-Martins J, Eris APM, Abdalla CMZ, Silva GDB, de Moura VPT, Sanches JA (2020) Management of dermatologic adverse events from cancer therapies: recommendations of an expert panel. An Bras Dermatol 95:221\u2013237","journal-title":"An Bras Dermatol"},{"key":"2623_CR3","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.jaad.2020.04.105","volume":"83","author":"SR Ellis","year":"2020","unstructured":"Ellis SR, Vierra AT, Millsop JW, Lacouture ME, Kiuru M (2020) Dermatologic toxicities to immune checkpoint inhibitor therapy: a review of histopathologic features. J Am Acad Dermatol 83:1130\u20131143","journal-title":"J Am Acad Dermatol"},{"key":"2623_CR4","unstructured":"HCUP National Inpatient Sample (NIS). Healthcare Cost and Utilization Project (HCUP). 2016\u20132019."},{"key":"2623_CR5","unstructured":"R Core Team. R: a language and environment for statistical computing. 2022. https:\/\/www.r-project.org\/. Accessed 15\u00a0 Aug 2022."},{"key":"2623_CR6","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1097\/MLR.0000000000001418","volume":"58","author":"HP Truong","year":"2020","unstructured":"Truong HP, Luke AA, Hammond G, Wadhera RK, Reidhead M, Joynt Maddox KE (2020) Utilization of social determinants of health ICD-10 Z-codes among hospitalized patients in the United States, 2016\u20132017. Med Care 58:1037\u20131043","journal-title":"Med Care"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-023-02623-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-023-02623-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-023-02623-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T06:05:00Z","timestamp":1693202700000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-023-02623-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,12]]},"references-count":6,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["2623"],"URL":"https:\/\/doi.org\/10.1007\/s00403-023-02623-4","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,12]]},"assertion":[{"value":"20 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"IRB approval status: IRB approval was not required as the study uses a publicly available data source with de-identified information.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}